Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management
NCT01766752 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-04-10
Summary
Objective: To investigate the performance (safety) of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at the general ward
Conditions
Interventions
- DEVICE
-
GlucoTab System
Tablet based workflow and decision support system with incorporated software algorithm (GlucoTab) used for glycaemic management in non-critically ill patients with type 2 diabetes at the general ward
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-03-31
- Completion
- 2013-04-30
Countries
- Austria
Study Locations
More Related Trials
-
Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use
NCT04033042 ·Status: COMPLETED ·Phase: NA
-
Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.
NCT04331444 ·Status: COMPLETED ·Phase: NA
-
Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.
NCT06607224 ·Status: COMPLETED ·Phase: NA
-
Clinical Risk Assesment of CS-1 Decision Support System
NCT00502645 ·Status: COMPLETED ·Phase: NA
-
Secondary Care - Continuous Glucose Monitoring
NCT03487887 ·Status: COMPLETED
-
Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors
NCT02155023 ·Status: COMPLETED ·Phase: NA
-
Metronom Continuous Glucose Monitoring System
NCT03341026 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)
NCT01763567 ·Status: COMPLETED
-
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
NCT01341067 ·Status: COMPLETED
-
Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes
NCT00401622 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System
NCT01514292 ·Status: COMPLETED ·Phase: NA
-
Glooko mHealth Advantage Study
NCT02974816 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm
NCT02087995 ·Status: COMPLETED ·Phase: NA
-
Experience With the Use of Continuous Glucose Monitoring (CGM) Devices in People With Type 2 Diabetes Mellitus
NCT07019753 ·Status: NOT_YET_RECRUITING
-
Examining The Role of CGM in T2DM
NCT01614262 ·Status: COMPLETED ·Phase: NA
-
Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward
NCT04871958 ·Status: TERMINATED ·Phase: NA
-
Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device
NCT01508065 ·Status: UNKNOWN
-
Time in Glucose Hospital Target
NCT05135676 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
NCT01831752 ·Status: COMPLETED
-
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
NCT01175408 ·Status: COMPLETED ·Phase: NA
-
Glucose to Goal: A Model to Support Diabetes Management in Primary Care
NCT02715934 ·Status: COMPLETED ·Phase: NA
-
Flash Glucose Monitoring Targets in Gestational Diabetes
NCT06774404 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes
NCT03781232 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes
NCT07089979 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device
NCT00433758 ·Status: UNKNOWN ·Phase: NA